Tirzepatide's Family Patents Explore Our Curated Drug Screens Drugs Generating Over $1 Billion in Annual Revenue Explore the top-performing drugs that dominate the pharmaceutical industry View List NCE-1 Patent Expiry in the Next 1 Year Identify opportunities as new chemical entity (NCE-1) patents approach expiry View List Recently Granted Patents in EP Find the opportunity to file Oppositions View List Clinical Trials Recent Clinical Trials on Tirzepatide: Sometimes companies keep conducting clinical trials even after the drug's approval to discover new formulations, methods of use, or new treatment indications, so they could file for additional patents or receive regulatory exclusivity extensions, such as pediatric exclusivity, potentially delaying generic competition
Balenovic D, Bencic ML, Udovicic M, Simonji K, Hanzevacki JS, Barisic I, et al
[DOI] [PubMed] [Google Scholar] 117.Correia ML, Haynes WG, Rahmouni K, Morgan DA, Sivitz WI, Mark AL
Patient-specific 503A compounding may continue to be available under narrow circumstances, specifically when there is a documented clinical reason a commercially available product cannot be used for that individual patient
R., Bariatric Internist Retatrutide appears to deliver weight-loss results that rival bariatric procedures
Call (954)-738-5886 to schedule your appointment
